Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1995-2-22
pubmed:abstractText
The interleukin 2 receptor gamma chain (IL-2R gamma) is a component of the receptors for IL-2, IL-4, IL-7, and IL-15. Mutations in IL-2R gamma in man appear responsible for the X chromosome-linked immunodeficiency SCIDX1, characterized by a defect in T-cell and natural killer (NK)-cell differentiation with the presence of poorly functioning B cells. To explore at which level IL-2R gamma affects lymphoid development in vivo, we have analyzed mice derived from embryonic stem (ES) cells with mutant IL-2R gamma loci generated by Cre/loxP-mediated recombination. In the peripheral blood of chimeric animals, lymphoid cells derived from IL-2R gamma- ES cells were not detected, although control ES cells carrying an IL-2R gamma gene with embedded loxP sites gave rise to T-, B-, and NK-cell lineages. Germline IL-2R gamma-deficient male animals, however, developed some mature splenic B and T cells, although the absolute number of lymphocytes was almost 10-fold reduced. In contrast, there was a complete disappearance of NK cells (over 350-fold reduction). Development of gut-associated intraepithelial lymphocytes was also severely diminished, and Peyer's patches were not detected. In vitro mitogenic responses of thymocytes, IL-4-directed immunoglobulin class switch of splenocytes, and NK activity were defective. Thus, IL-2R gamma facilitates mainstream B- and T-cell generation and function and also appears to be essential for NK-cell development.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-1631559, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-1799668, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-1824857, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-1827140, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-1830926, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-1899373, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-1948049, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-2033373, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-2212666, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-3086872, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-421372, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-7517363, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-7805729, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8016642, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8026467, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8034332, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8046341, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8128231, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8216725, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8266076, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8266077, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8266078, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8315381, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8402911, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8415665, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8462096, http://linkedlifedata.com/resource/pubmed/commentcorrection/7831294-8513499
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
17
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
377-81
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:7831294-Animals, pubmed-meshheading:7831294-Base Sequence, pubmed-meshheading:7831294-Bone Marrow Cells, pubmed-meshheading:7831294-Chimera, pubmed-meshheading:7831294-Disease Models, Animal, pubmed-meshheading:7831294-Flow Cytometry, pubmed-meshheading:7831294-Intestine, Small, pubmed-meshheading:7831294-Lymphatic System, pubmed-meshheading:7831294-Lymphocytes, pubmed-meshheading:7831294-Lymphoid Tissue, pubmed-meshheading:7831294-Male, pubmed-meshheading:7831294-Mice, pubmed-meshheading:7831294-Mice, Mutant Strains, pubmed-meshheading:7831294-Molecular Sequence Data, pubmed-meshheading:7831294-Peyer's Patches, pubmed-meshheading:7831294-Receptors, Interleukin-2, pubmed-meshheading:7831294-Sequence Deletion, pubmed-meshheading:7831294-Severe Combined Immunodeficiency, pubmed-meshheading:7831294-Spleen, pubmed-meshheading:7831294-Stem Cells, pubmed-meshheading:7831294-Thymus Gland, pubmed-meshheading:7831294-X Chromosome
pubmed:year
1995
pubmed:articleTitle
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.
pubmed:affiliation
Institut National de la Santé et de la Recherche Médicale, Unité 132, Hôpital Necker-Enfants Malades, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't